Jan Åhlén

441 total citations
20 papers, 352 citations indexed

About

Jan Åhlén is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Jan Åhlén has authored 20 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Gastroenterology and 5 papers in Surgery. Recurrent topics in Jan Åhlén's work include Gastrointestinal Tumor Research and Treatment (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Gastrointestinal disorders and treatments (5 papers). Jan Åhlén is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Gastrointestinal disorders and treatments (5 papers). Jan Åhlén collaborates with scholars based in Sweden, United States and Serbia. Jan Åhlén's co-authors include Catharina Larsson, Weng‐Onn Lui, Wen‐Hui Weng, Robert Bränström, Olle Larsson, Johan Wejde, Otte Brosjö, Erik Berglund, Anette von Rosen and Pınar Akçakaya and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Jan Åhlén

18 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Åhlén Sweden 10 171 100 90 80 75 20 352
Hiroyuki Hiraki Japan 10 171 1.0× 109 1.1× 80 0.9× 35 0.4× 97 1.3× 15 372
Séverine Tabone‐Eglinger France 12 209 1.2× 74 0.7× 194 2.2× 61 0.8× 83 1.1× 28 446
Lope Estévéz‐Schwarz Germany 10 218 1.3× 150 1.5× 39 0.4× 77 1.0× 83 1.1× 10 482
Megan H. Crawley United States 8 127 0.7× 79 0.8× 154 1.7× 51 0.6× 139 1.9× 10 389
Jasmien Cornillie Belgium 14 330 1.9× 87 0.9× 111 1.2× 65 0.8× 211 2.8× 27 471
Tambudzai Shamu United States 6 293 1.7× 246 2.5× 141 1.6× 46 0.6× 74 1.0× 7 506
Maria Giulia Pirini Italy 10 225 1.3× 81 0.8× 83 0.9× 66 0.8× 83 1.1× 26 418
I Nishimori Japan 8 183 1.1× 139 1.4× 33 0.4× 69 0.9× 129 1.7× 13 540
Hege O. Ohnstad Norway 9 192 1.1× 179 1.8× 37 0.4× 29 0.4× 188 2.5× 15 445
Silvia Gisfredi Italy 14 169 1.0× 241 2.4× 25 0.3× 57 0.7× 219 2.9× 25 598

Countries citing papers authored by Jan Åhlén

Since Specialization
Citations

This map shows the geographic impact of Jan Åhlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Åhlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Åhlén more than expected).

Fields of papers citing papers by Jan Åhlén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Åhlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Åhlén. The network helps show where Jan Åhlén may publish in the future.

Co-authorship network of co-authors of Jan Åhlén

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Åhlén. A scholar is included among the top collaborators of Jan Åhlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Åhlén. Jan Åhlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Östberg, Viveca, et al.. (2023). Psychosomatic complaints at age 15-16 and later educational achievement in upper secondary school. European Journal of Public Health. 33(Supplement_2).
2.
Östberg, Viveca, Jan Åhlén, & Sara Brolin Låftman. (2023). Educational attainment and symptoms of anxiety and depression in young adulthood. European Journal of Public Health. 33(Supplement_2). 2 indexed citations
3.
Zhang, Yifan, Robert Bränström, Jan Åhlén, et al.. (2022). The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center. International Journal of Cancer. 151(6). 906–913. 7 indexed citations
4.
Juhlin, C. Christofer, Henrik Falhammar, Magnus Kjellman, et al.. (2020). Highly proliferative anal neuroendocrine carcinoma: molecular and clinical features of a rare, recurrent case in complete remission. BMC Gastroenterology. 20(1). 290–290. 2 indexed citations
5.
Berglund, Erik, David Berglund, Inga‐Lena Nilsson, et al.. (2020). Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors. Cancer Immunology Immunotherapy. 69(11). 2393–2401. 20 indexed citations
6.
Åhlén, Jan. (2019). The EU effect and the export of environmental standards to the U.S.. Carolina Digital Repository (University of North Carolina at Chapel Hill).
7.
Huang, Wen‐Kuan, Pınar Akçakaya, Anastasia Gangaev, et al.. (2018). miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors. Experimental Cell Research. 371(1). 287–296. 33 indexed citations
8.
Åhlén, Jan, et al.. (2018). Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs). World Journal of Surgery. 42(8). 2512–2521. 14 indexed citations
9.
Akçakaya, Pınar, Stefano Caramuta, Jan Åhlén, et al.. (2014). microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome. British Journal of Cancer. 111(11). 2091–2102. 47 indexed citations
10.
Berglund, Erik, S. J. Kumari A. Ubhayasekera, Pınar Akçakaya, et al.. (2013). Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells. Anti-Cancer Drugs. 25(4). 415–422. 12 indexed citations
11.
Brosjö, Otte, et al.. (2013). [Hemicorporectomy can give life back].. PubMed. 110(3). 90–1. 2 indexed citations
12.
Åhlén, Jan, Johan Westerdahl, Jan Zedenius, et al.. (2012). Side-effects from imatinib treatment of advanced GIST–associated with a better outcome. 1(1). 11–11. 3 indexed citations
13.
Larsson, Olle, et al.. (2011). Solitary fibrous tumor of the prostate: A report of two cases. Pathology International. 61(9). 536–538. 10 indexed citations
14.
Åhlén, Jan, Johan Wejde, Otte Brosjö, et al.. (2005). Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma. Clinical Cancer Research. 11(1). 206–216. 57 indexed citations
15.
Weng, Wen‐Hui, Mikael Lerner, Dan Grandér, et al.. (2005). Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity. International Journal of Oncology. 26(1). 5–16. 4 indexed citations
16.
Weng, Wen‐Hui, et al.. (2005). Prognostic Impact of Immunohistochemical Expression of Ezrin in Highly Malignant Soft Tissue Sarcomas. Clinical Cancer Research. 11(17). 6198–6204. 99 indexed citations
17.
Weng, Wen‐Hui, Johan Wejde, Jan Åhlén, et al.. (2004). Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. Cancer Genetics and Cytogenetics. 150(1). 27–32. 13 indexed citations
18.
Åhlén, Jan, Weng‐Onn Lui, Otte Brosjö, et al.. (2003). Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. British Journal of Cancer. 89(4). 720–726. 16 indexed citations
19.
Åhlén, Jan, et al.. (2003). Evaluation of immunohistochemical parameters as prognostic markers in malignant fibrous histiocytoma. Oncology Reports. 10(5). 1641–5. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Hiraki Breakdown of academic impact, for papers by Séverine Tabone‐Eglinger Breakdown of academic impact, for papers by Lope Estévéz‐Schwarz Breakdown of academic impact, for papers by Megan H. Crawley Breakdown of academic impact, for papers by Jasmien Cornillie Breakdown of academic impact, for papers by Tambudzai Shamu Breakdown of academic impact, for papers by Maria Giulia Pirini Breakdown of academic impact, for papers by I Nishimori Breakdown of academic impact, for papers by Hege O. Ohnstad Breakdown of academic impact, for papers by Silvia Gisfredi
Rankless by CCL
2026